Quick Answer
BIO-RAD LABORATORIES, INC. reported Stockholders Equity of $7.45 billion for fiscal year 2025.
BIO-RAD LABORATORIES, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $7.45B | +13.5% |
| 2024 | $6.57B | -24.8% |
| 2023 | $8.74B | -9.1% |
| 2022 | $9.62B | -29.7% |
| 2021 | $13.69B | +38.4% |
| 2020 | $9.89B | +71.8% |
| 2019 | $5.76B | +43.2% |
| 2018 | $4.02B | +37.2% |
| 2017 | $2.93B | +13.6% |
| 2016 | $2.58B | +3.8% |
| 2015 | $2.49B | +13.8% |
| 2014 | $2.18B | -0.1% |
| 2013 | $2.19B | +8.5% |
| 2012 | $2.02B | +15.5% |
| 2011 | $1.74B | +13.5% |
| 2010 | $1.54B | +22.0% |
| 2009 | $1.26B | +17.7% |
| 2008 | $1.07B | +6.4% |
| 2007 | $1.01B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.74B | -10.0% | -5.5% |
| June 30, 2025 | $7.13B | +5.2% | +6.7% |
| March 31, 2025 | $6.68B | -26.2% | +1.7% |
| December 31, 2024 | $6.57B | -24.8% | -12.3% |
| September 30, 2024 | $7.49B | -11.0% | +10.5% |
| June 30, 2024 | $6.78B | -19.7% | -25.1% |
| March 31, 2024 | $9.05B | -7.3% | +3.5% |
| December 31, 2023 | $8.74B | -9.1% | +3.9% |
- BIO-RAD LABORATORIES, INC. showed an increase of +13.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, BIO-RAD LABORATORIES, INC.’s stockholders equity has grown by 640.8% (from $1.01 billion to $7.45 billion).
- The most recent figure is from BIO-RAD LABORATORIES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: